+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine



Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine



International Journal of Molecular Sciences 18(9):



Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to their capacity for local engrafting and differentiating into multiple tissue types. However, recent studies have revealed that implanted cells do not survive for long, and that the benefits of MSC therapy could be due to the vast array of bioactive factors they produce, which play an important role in the regulation of key biologic processes. Secretome derivatives, such as conditioned media or exosomes, may present considerable advantages over cells for manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biologic product. Nevertheless, regulatory requirements for manufacturing and quality control will be necessary to establish the safety and efficacy profile of these products. Among MSCs, human uterine cervical stem cells (hUCESCs) may be a good candidate for obtaining secretome-derived products. hUCESCs are obtained by Pap cervical smear, which is a less invasive and painful method than those used for obtaining other MSCs (for example, from bone marrow or adipose tissue). Moreover, due to easy isolation and a high proliferative rate, it is possible to obtain large amounts of hUCESCs or secretome-derived products for research and clinical use.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059959830

Download citation: RISBibTeXText

PMID: 28841158

DOI: 10.3390/ijms18091852


Related references

The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine. Cytokine and Growth Factor Reviews 46: 1-9, 2019

Therapeutic application of mesenchymal stem cell-derived exosomes: A promising cell-free therapeutic strategy in regenerative medicine. Cellular and Molecular Biology 62(7): 74-79, 2016

Mesenchymal stem cells secretome: a new therapeutic tool for Parkinsons disease regenerative medicine?. European Neuropsychopharmacology 27: S687-S688, 2017

Pilot Production of Mesenchymal Stem/Stromal Freeze-Dried Secretome for Cell-Free Regenerative Nanomedicine: A Validated GMP-Compliant Process. Cells 7(11):, 2018

Human embryonic stem cell derived-mesenchymal stem cells: an alternative mesenchymal stem cell source for regenerative medicine therapy. Regenerative Medicine 9(4): 453-465, 2014

Mesenchymal stem cell secretome and regenerative therapy after cancer. 2013

Mesenchymal stem cell secretome and regenerative therapy after cancer. Biochimie 95(12): 2235-2245, 2013

Towards an ideal source of mesenchymal stem cell isolation for possible therapeutic application in regenerative medicine. Biomedical Papers of the Medical Faculty of the University Palacky Olomouc Czechoslovakia 158(3): 356-360, 2014

Secretome of mesenchymal stem/stromal cells in regenerative medicine. Biochimie 95(12): 2195, 2013

Mesenchymal stem cell-derived secretome and microvesicles as a cell-free therapeutics for neurodegenerative disorders. Tissue Engineering and Regenerative Medicine 10(3): 93-101, 2013

MSC 2007--Adult Mesenchymal Stem Cells in Regenerative Medicine. Developments in stem cell therapeutic research. 27-29 August 2007, Cleveland, OH, USA. Idrugs 10(11): 787-790, 2007

Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Can Preconditioning Strategies Improve Therapeutic Efficacy?. Transfusion Medicine and HemoTherapy 43(4): 256-267, 2016

Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annual Review of Immunology 31: 285-316, 2013

Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases role of secretome and exosomes. Biochimie, 2013

Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes. Biochimie 95(12): 2229-2234, 2013